Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will rename the following tests:
- The Cancer Gene Mutation Panel Version 2 (test code 9705) will be the Solid Tumor Mutation Panel.
- The Leukemia Mutation Panel (test code 9715) will be the Hematologic Malignancy Mutation Panel.
Baylor Genetics is a joint venture of H.U. Group Holdings and the #1 NIH-funded genetics program at Baylor College of Medicine. A pioneer of precision medicine for nearly 40 years, Baylor Genetics now offers a full spectrum of clinically relevant genetic testing, access to world-renowned experts, and the confidence to provide patients with the best care. Baylor Genetics, located in Houston’s Texas Medical Center, serves clients in 50 states and 16 countries.